Ocumension Therapeutics Balance Sheet Health

Financial Health criteria checks 5/6

Ocumension Therapeutics has a total shareholder equity of CN¥2.8B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥3.0B and CN¥257.7M respectively.

Key information

0%

Debt to equity ratio

CN¥0

Debt

Interest coverage ration/a
CashCN¥972.91m
EquityCN¥2.77b
Total liabilitiesCN¥257.68m
Total assetsCN¥3.03b

Recent financial health updates

Recent updates

With Ocumension Therapeutics (HKG:1477) It Looks Like You'll Get What You Pay For

Sep 21
With Ocumension Therapeutics (HKG:1477) It Looks Like You'll Get What You Pay For

Analysts Are Upgrading Ocumension Therapeutics (HKG:1477) After Its Latest Results

Aug 15
Analysts Are Upgrading Ocumension Therapeutics (HKG:1477) After Its Latest Results

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Ocumension Therapeutics' (HKG:1477) CEO For Now

Jun 13
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Ocumension Therapeutics' (HKG:1477) CEO For Now

Ocumension Therapeutics' (HKG:1477) P/S Still Appears To Be Reasonable

Apr 29
Ocumension Therapeutics' (HKG:1477) P/S Still Appears To Be Reasonable

Here's Why We're Not Too Worried About Ocumension Therapeutics' (HKG:1477) Cash Burn Situation

Mar 14
Here's Why We're Not Too Worried About Ocumension Therapeutics' (HKG:1477) Cash Burn Situation

Some Analysts Just Cut Their Ocumension Therapeutics (HKG:1477) Estimates

Aug 29
Some Analysts Just Cut Their Ocumension Therapeutics (HKG:1477) Estimates

We're Hopeful That Ocumension Therapeutics (HKG:1477) Will Use Its Cash Wisely

Jul 13
We're Hopeful That Ocumension Therapeutics (HKG:1477) Will Use Its Cash Wisely

Is Ocumension Therapeutics (HKG:1477) Trading At A 48% Discount?

Jun 02
Is Ocumension Therapeutics (HKG:1477) Trading At A 48% Discount?

We're Not Very Worried About Ocumension Therapeutics' (HKG:1477) Cash Burn Rate

Jan 20
We're Not Very Worried About Ocumension Therapeutics' (HKG:1477) Cash Burn Rate

We're Not Very Worried About Ocumension Therapeutics' (HKG:1477) Cash Burn Rate

Sep 27
We're Not Very Worried About Ocumension Therapeutics' (HKG:1477) Cash Burn Rate

Could The Ocumension Therapeutics (HKG:1477) Ownership Structure Tell Us Something Useful?

Jan 23
Could The Ocumension Therapeutics (HKG:1477) Ownership Structure Tell Us Something Useful?

Financial Position Analysis

Short Term Liabilities: 1477's short term assets (CN¥1.2B) exceed its short term liabilities (CN¥224.9M).

Long Term Liabilities: 1477's short term assets (CN¥1.2B) exceed its long term liabilities (CN¥32.7M).


Debt to Equity History and Analysis

Debt Level: 1477 is debt free.

Reducing Debt: 1477 currently has no debt however we can't compare to 5 years ago as we have no data for that period.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: 1477 has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if 1477 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Discover healthy companies